Blood-brain barrier integrity in a mouse model of Alzheimer's disease with or without acute 3D6 immunotherapy-Reference-Cited by-同舟云学术

Blood-brain barrier integrity in a mouse model of Alzheimer's disease with or without acute 3D6 immunotherapy

Published:2018-12 Issue: Volume:143 Page:1-9
ISSN:0028-3908
Container-title:Neuropharmacology
language:en
Short-container-title:Neuropharmacology

Author:

Gustafsson Sofia,Gustavsson Tobias,Roshanbin Sahar,Hultqvist Greta,Hammarlund-Udenaes Margareta,Sehlin Dag,Syvänen Stina

Funder

Swedish Research Council

Alzheimerfonden

Åhlén-stiftelsen

Stiftelsen Fondkistan

Magnus Bergwalls stiftelse

Stohnes Stiftelse

Stiftelsen för gamla tjänarinnor

Goljes stiftelse

Publisher

Elsevier BV

Subject

Cellular and Molecular Neuroscience,Pharmacology

Reference52 articles.

1. Progression of cerebral amyloid angiopathy: accumulation of amyloid-beta40 in affected vessels;Alonzo;J. Neuropathol. Exp. Neurol.,1998

2. Amyloid-related imaging abnormalities-haemosiderin (ARIA-H) in patients with Alzheimer's disease treated with bapineuzumab: a historical, prospective secondary analysis;Arrighi;J. Neurol. Neurosurg. Psychiatry,2016

3. Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease;Bard;Nat. Med.,2000

4. Lack of widespread BBB disruption in alzheimer's disease models: focus on therapeutic antibodies;Bien-Ly;Neuron,2015

5. Amyloid triggers extensive cerebral angiogenesis causing blood brain barrier permeability and hypervascularity in Alzheimer's disease;Biron;PLoS One,2011

Cited by 27 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Circulating Exosomes from Alzheimer’s Disease Suppress Vascular Endothelial-Cadherin Expression and Induce Barrier Dysfunction in Recipient Brain Microvascular Endothelial Cell;Journal of Alzheimer's Disease;2023-09-26

2. Age, dose, and binding to TfR on blood cells influence brain delivery of a TfR-transported antibody;Fluids and Barriers of the CNS;2023-05-11

3. Circulating exosomes from Alzheimer’s disease suppress VE-cadherin expression and induce barrier dysfunction in recipient brain microvascular endothelial cell;2023-04-06

4. ImmunoPET imaging of amyloid-beta in a rat model of Alzheimer’s disease with a bispecific, brain-penetrating fusion protein;Translational Neurodegeneration;2022-12-26

5. Blood–brain barrier penetrating neprilysin degrades monomeric amyloid-beta in a mouse model of Alzheimer’s disease;Alzheimer's Research & Therapy;2022-12-05